Epalrestat
Epalrestat CAS No.: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat yo itilize pou anpeche, amelyore, ak trete periferik neropatik (pèt sansasyon, doulè), parèstezi Vibration, ak kadyak anomali ki asosye ak dyabèt. SPESIFIKASYON
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat yo itilize pou anpeche, amelyore, ak trete periferik neropatik (pèt sansasyon, doulè), parèstezi Vibration, ak kadyak anomali ki asosye ak dyabèt. SPESIFIKASYON
P roduct non | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Ekri mesaj ou isit la epi voye li ban nou